Unfractionated heparin dosing nomograms: road maps to where?

Area of Science:

• Pharmacology and Therapeutics
• Hematology

Background:

• Weight-adjusted nomograms represent an advancement in unfractionated heparin (UFH) dosing.
• Clinical trials show weight-adjusted nomograms achieve therapeutic activated partial thromboplastin time (aPTT) faster than standard UFH.
• Despite advancements, achieving and maintaining therapeutic aPTT remains a challenge, with many patients experiencing subtherapeutic or supratherapeutic levels.

Purpose of the Study:

• To evaluate the effectiveness and limitations of weight-adjusted nomograms for UFH dosing.
• To highlight the real-world challenges in maintaining therapeutic anticoagulation with UFH nomograms.
• To underscore the need for improved anticoagulant strategies.

Main Methods:

• Review of clinical trial data and real-world experiences with weight-adjusted UFH nomograms.
• Analysis of patient outcomes regarding therapeutic aPTT levels.
• Assessment of nomogram consistency and training requirements.

Main Results:

• Weight-adjusted nomograms expedite reaching a therapeutic aPTT but do not consistently maintain it.
• Real-world data confirm difficulties in keeping UFH within the therapeutic range using nomograms.
• Existing nomograms lack consistency and necessitate extensive training, increasing the risk of medication errors.

Conclusions:

• While UFH nomograms offer an improvement over standard dosing, their inherent limitations persist.
• The variability and complexity of current nomograms impede optimal patient care.
• There is a clear need for the development of more predictable and easily manageable anticoagulants.